• In late April 2026, Trip.com Group disclosed that it had completed two share repurchase tranches totaling 20,285,355 shares for about US$916.00 million, while simultaneously facing multiple securities class action lawsuits alleging it misled investors about escalating antitrust and monopolistic regulatory risks tied to its AI pricing practices in China.
• The combination of completed buybacks and mounting legal actions over the now‑shuttered AI price adjustment tool raises questions about how capital allocation, governance, and regulatory compliance may interact for Trip.com Group going forward.
• We’ll now examine how the emerging antitrust investigations and related class action lawsuits may reshape Trip.com Group’s existing investment narrative.

AI is about to change healthcare. These 35 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Trip.com Group Investment Narrative Recap

To own Trip.com Group, you have to believe in long term growth in Asian travel and in the company’s ability to convert high app engagement into profitable bookings. In the near term, the key catalyst remains travel demand in and out of China, while the biggest emerging risk is regulatory and legal pressure around its past AI pricing practices. The latest buyback and class action filings are relevant, but do not yet appear to alter that core thesis in a decisive way.

The completion of two repurchase programs totaling about US$916.0 million, including 20,057,854 shares under the long running 2014 authorization, shows Trip.com Group continuing to return cash to shareholders even as antitrust investigations unfold. That capital return sits alongside strong reported 2025 results, but investors may now weigh it against potential legal liabilities and any future compliance related costs, especially if Chinese regulators tighten oversight around pricing tools and monopolistic conduct.

Yet behind the strong travel demand story, investors should be aware of how an extended antitrust probe could...

Trip.com Group's narrative projects CN¥89.4 billion revenue and CN¥23.1 billion earnings by 2029.

Uncover how Trip.com Group's forecasts yield a $76.49 fair value, a 43% upside to its current price.

Exploring Other Perspectives

Three fair value estimates from the Simply Wall St Community span roughly US$76 to US$157 per share, underlining how far apart individual views can be. When you set those side by side with the growing focus on Trip.com Group’s monopolistic risk and AI pricing scrutiny, it becomes clear that understanding several contrasting risk and reward narratives is essential before forming your own view.

Explore 3 other fair value estimates on Trip.com Group - why the stock might be worth over 2x more than the current price!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Trip.com Group research is our analysis highlighting 4 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Trip.com Group research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Trip.com Group's overall financial health at a glance.

Interested In Other Possibilities?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

• Explore 27 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
• Capitalize on the AI infrastructure supercycle with our selection of the 40 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• We've uncovered the 12 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.